BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

156 related articles for article (PubMed ID: 24613742)

  • 1. Splenic artery ligation for severe oxaliplatin induced portal hypertension: a way to improve postoperative course and allow adjuvant chemotherapy for colorectal liver metastases.: Letter to editor: comment about "Nodular regenerative hyperplasia (NRH) complicating oxaliplatin chemotherapy in patients undergoing resection of colorectal liver metastases".
    Schwarz L; Faitot F; Soubrane O; Scatton O
    Eur J Surg Oncol; 2014 Jun; 40(6):787-8. PubMed ID: 24613742
    [No Abstract]   [Full Text] [Related]  

  • 2. Nodular regenerative hyperplasia (NRH) complicating oxaliplatin chemotherapy in patients undergoing resection of colorectal liver metastases.
    Morris-Stiff G; White AD; Gomez D; Cameron IC; Farid S; Toogood GJ; Lodge JP; Prasad KR
    Eur J Surg Oncol; 2014 Aug; 40(8):1016-20. PubMed ID: 24370284
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nodular Regenerative Hyperplasia in Patients Undergoing Liver Resection for Colorectal Metastases After Chemotherapy: Risk Factors, Preoperative Assessment and Clinical Impact.
    Viganò L; Rubbia-Brandt L; De Rosa G; Majno P; Langella S; Toso C; Mentha G; Capussotti L
    Ann Surg Oncol; 2015 Dec; 22(13):4149-57. PubMed ID: 25845431
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Nodular regenerative hyperplasia: a deleterious consequence of chemotherapy for colorectal liver metastases?
    Hubert C; Sempoux C; Horsmans Y; Rahier J; Humblet Y; Machiels JP; Ceratti A; Canon JL; Gigot JF
    Liver Int; 2007 Sep; 27(7):938-43. PubMed ID: 17696932
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Predicting high grade lesions of sinusoidal obstruction syndrome related to oxaliplatin-based chemotherapy for colorectal liver metastases: correlation with post-hepatectomy outcome.
    Soubrane O; Brouquet A; Zalinski S; Terris B; Brézault C; Mallet V; Goldwasser F; Scatton O
    Ann Surg; 2010 Mar; 251(3):454-60. PubMed ID: 20160638
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hepatic veno-occlusive disease after neoadjuvant treatment of colorectal liver metastases with oxaliplatin: a lesson of the month.
    Schouten van der Velden AP; Punt CJ; Van Krieken JH; Derleyn VA; Ruers TJ
    Eur J Surg Oncol; 2008 Mar; 34(3):353-5. PubMed ID: 17207961
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [A case of liver failure associated with liver damage due to mFOLFOX 6 after resection for multiple liver metastases from colorectal cancer].
    Ishizaki T; Abe T; Koyanagi Y; Katsumata K; Wada T; Tsuchida A; Aoki T
    Gan To Kagaku Ryoho; 2007 Jun; 34(6):945-8. PubMed ID: 17565263
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Reversibility of chemotherapy-related liver injury.
    Vigano L; De Rosa G; Toso C; Andres A; Ferrero A; Roth A; Sperti E; Majno P; Rubbia-Brandt L
    J Hepatol; 2017 Jul; 67(1):84-91. PubMed ID: 28284915
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Portal hypertension associated with oxaliplatin administration: clinical manifestations of hepatic sinusoidal injury.
    Slade JH; Alattar ML; Fogelman DR; Overman MJ; Agarwal A; Maru DM; Coulson RL; Charnsangavej C; Vauthey JN; Wolff RA; Kopetz S
    Clin Colorectal Cancer; 2009 Oct; 8(4):225-30. PubMed ID: 19822514
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A prospective study of isolated human hepatocyte function following liver resection for colorectal liver metastases: the effects of prior exposure to chemotherapy.
    Hewes JC; Riddy D; Morris RW; Woodrooffe AJ; Davidson BR; Fuller B
    J Hepatol; 2006 Aug; 45(2):263-70. PubMed ID: 16635536
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Splenic arterial ligation prevents liver injury after a major hepatectomy by a reduction of surplus portal hypertension in hepatocellular carcinoma patients with cirrhosis.
    Sato Y; Kobayashi T; Nakatsuka H; Yamamoto S; Oya H; Watanabe T; Hatakeyama K
    Hepatogastroenterology; 2001; 48(39):831-5. PubMed ID: 11462934
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Sinusoidal obstruction syndrome and nodular regenerative hyperplasia are frequent oxaliplatin-associated liver lesions and partially prevented by bevacizumab in patients with hepatic colorectal metastasis.
    Rubbia-Brandt L; Lauwers GY; Wang H; Majno PE; Tanabe K; Zhu AX; Brezault C; Soubrane O; Abdalla EK; Vauthey JN; Mentha G; Terris B
    Histopathology; 2010 Mar; 56(4):430-9. PubMed ID: 20459550
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Re: Preoperative chemotherapy and the outcome of liver resection for colorectal metastases.
    Hewes J
    World J Surg; 2007 Sep; 31(9):1902. PubMed ID: 17487524
    [No Abstract]   [Full Text] [Related]  

  • 14. Impact of biological agents on the prevalence of chemotherapy associated liver injury (CALI): Multicentric study of patients operated for colorectal liver metastases.
    Hubert C; Lucidi V; Weerts J; Dili A; Demetter P; Massart B; Komuta M; Navez J; Reding R; Gigot JF; Sempoux C
    Eur J Surg Oncol; 2018 Oct; 44(10):1532-1538. PubMed ID: 30093084
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Hepatic sinusoidal obstruction syndrome (SOS) reduces the effect of oxaliplatin in colorectal liver metastases.
    Vreuls CP; Van Den Broek MA; Winstanley A; Koek GH; Wisse E; Dejong CH; Olde Damink SW; Bosman FT; Driessen A
    Histopathology; 2012 Aug; 61(2):314-8. PubMed ID: 22571348
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Hyaluronic acid as a marker of hepatic sinusoidal obstruction syndrome secondary to oxaliplatin-based chemotherapy in patients with colorectal liver metastases.
    van den Broek MA; Vreuls CP; Winstanley A; Jansen RL; van Bijnen AA; Dello SA; Bemelmans MH; Dejong CH; Driessen A; Olde Damink SW
    Ann Surg Oncol; 2013 May; 20(5):1462-9. PubMed ID: 23463086
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Liver histology and surgical outcomes after preoperative chemotherapy with fluorouracil plus oxaliplatin in colorectal cancer liver metastases.
    Aloia T; Sebagh M; Plasse M; Karam V; Lévi F; Giacchetti S; Azoulay D; Bismuth H; Castaing D; Adam R
    J Clin Oncol; 2006 Nov; 24(31):4983-90. PubMed ID: 17075116
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatocellular carcinoma and nodular regenerative hyperplasia after chemotherapy for metastatic colorectal carcinoma.
    Calderaro J; Azoulay D; Zafrani ES
    Hepatology; 2014 Oct; 60(4):1440-1. PubMed ID: 24604623
    [No Abstract]   [Full Text] [Related]  

  • 19. Development of nodular regenerative hyperplasia (NRH) with portal hypertension following the administration of oxaliplatin for the recurrence of colon cancer.
    Takaya H; Kawaratani H; Nakanishi K; Takeyama S; Morioka C; Sawai M; Toyohara M; Fujimoto M; Yoshiji H; Yamao J; Fukui H
    Intern Med; 2015; 54(4):383-7. PubMed ID: 25748953
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Combined first-stage hepatectomy and colorectal resection in a two-stage hepatectomy strategy for bilobar synchronous liver metastases.
    Karoui M; Vigano L; Goyer P; Ferrero A; Luciani A; Aglietta M; Delbaldo C; Cirillo S; Capussotti L; Cherqui D
    Br J Surg; 2010 Sep; 97(9):1354-62. PubMed ID: 20603857
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.